交易 Compass Pathways PLC - ADR - CMPS 差價合約

交易條件

• 類型: 差價合約
• 點差: 0.05
• 長倉隔夜倉息調整: -0.02185%
• 短倉隔夜倉息調整: -0.00038%
• 隔夜倉息調整時間: 22:00 (UTC)
• 貨幣: USD
• 最低成交量: 10
• 保證金: 5.00%
• 證券交易所: United States of America
• 交易佣金: 0%
• 保證止損溢價: 1%

主要統計數據

• 前收盤價: 6.56
• 開倉: 6.47
• 1 年變化: 53.68%
• 日區間: 6.22 - 6.58

Compass Pathways PLC - ADR (NASDAQ: CMPS) is a UK-based mental health biotech developing psilocybin-based therapies for treatment-resistant depression. Its lead candidate, COMP360, is in Phase 3 trials and aims to become the first FDA-approved psychedelic-assisted therapy. Compass is a high-risk, high-reward biotech tied to the future of mental healthcare and psychedelic medicine.